Page 3 - உலகம் காங்கிரஸ் ஆன் இரைப்பை குடல் புற்றுநோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Imugene presents HER-Vaxx cancer immunotherapy program at ESMO World Congress on Gastrointestinal Cancer 2021 annual meeting Imugene is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumours. The presentation expanded on previously presented interim analysis data presented at AACR2021. Imugene Ltd (ASX:IMU) (OTCMKTS:IUGNF) has presented its HER-Vaxx cancer immunotherapy program at the ESMO World Congress on Gastrointestinal Cancer 2021 annual meeting. The abstract presentation was entitled ‘Herizon: A Phase1B/2 open-label study of IMU-131 Her2/NEU peptide vaccine plus standard care of chemotherapy with randomisation in phase-2 in patients with Her2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach of gastroesophageal junction’ updated interim analysis results’.

World congress on gastrointestinal cancerGastrointestinal cancerOverall response rateஉலகம் காங்கிரஸ் ஆன் இரைப்பை குடல் புற்றுநோய்இரைப்பை குடல் புற்றுநோய்ஓவரால் பதில் ரேட்